Angiomotin-Like Protein 2 (AMOTL2) Antibody

Este producto es parte de AMOT - Angiomotin (like)
Product Graph
357.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Angiomotin-Like Protein 2 (AMOTL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx036363
tested applications
ELISA, WB, IHC

Description

Rabbit Polyclonal against the AMOTL2 protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Angiomotin-Like Protein 2 (AMOTL2)
Immunogen: Recombinant fragment corresponding to 6-235 AA of human AMOTL2.
Host
Rabbit
Reactivity
Human
Assay Type
Concentration: Lyophilized form: Not applicable.  After reconstitution: 1 mg/ml.
Recommended Dilution
ELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
Observed MW: 86 kDa
Purification
Purified by antigen affinity column chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Lyophilized
Tested Applications
ELISA, WB, IHC
Buffer
Prior to lyophilization: 1% BSA and 0.02% NaN3.
Availability
Shipped within 7-15 working days.
Storage
Store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
LCCP
Background
Antibody anti-AMOTL2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

AMOTL2 is a member of the angiomotin (AMOT) protein family which regulates cellular processes such as angiogenesis, cell polarity, migration, and proliferation. AMOTL2 interacts with components of the Hippo signaling pathway specifically binding to YAP (Yes-associated protein) and TAZ (transcriptional co-activator with PDZ-binding motif) to regulate gene expression and maintain tissue homeostasis. By inhibiting YAP/TAZ nuclear translocation AMOTL2 acts as a tumor suppressor controlling cell proliferation and limiting excessive tissue growth. AMOTL2 plays a critical role in vascular development by stabilizing endothelial cell junctions and maintaining endothelial barrier integrity during angiogenesis. It interacts with cytoskeletal components such as actin filaments to mediate endothelial cell polarity and migration processes that are essential for blood vessel formation. AMOTL2 also regulates epithelial cell polarity during embryonic development influencing organogenesis and tissue architecture. In cancer biology AMOTL2 has dual roles depending on the cellular context. It can function as a tumor suppressor by restricting oncogenic YAP/TAZ signaling and inhibiting cell migration while in some cancers its dysregulation may promote tumor progression, metastasis, and angiogenesis. AMOTL2’s ability to control cell-cell junction stability and its involvement in actin cytoskeleton remodeling make it a key regulator of cellular structure and migration.

Related Products

P9256

Recombinant Human AMOTL2

Ver Producto
abx036363

Angiomotin-Like Protein 2 (AMOTL2) Antibody

Rabbit Polyclonal against the AMOTL2 protein.

Ver Producto
abx241185

Angiomotin-like protein 2 (AMOTL2) Antibody

AMOTL2 Antibody is a Rabbit Polyclonal against AMOTL2.

Ver Producto